Tango Therapeutics, Inc (TNGX) Announces 15.5M Share Offering at $5.15/sh Aug 10, 2023 07:01AM
Tango Therapeutics Announces $80 million Private Placement Financing Aug 10, 2023 07:00AM
Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer Therapies Aug 10, 2021 09:00AM